Drug Trial Radar · NCT01147627
Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
Last checked: Nov 20, 2026Latest source record: Aug 21, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
416
Actual
Start
Aug 2010
Primary completion
Aug 2012
Study completion Dec 2012
Sponsor
- Lead sponsor
- Sun Yat-sen UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Eli Lilly and Company; Amylin Pharmaceuticals, LLC.; Ministry of Health, China
- First posted
- Jun 22, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate and evaluate the effects of different interventions (1. exenatide, 2. insulin, 3. thiazolidinedione) on glycemic control and β-cell function in newly diagnosed drug-naïve type 2 diabetic patients.
Conditions
- Diabetes Mellitus, Type 2
- Newly Diagnosed
Interventions
exenatide injectionDrug
Patients in exenatide group will be treated with exenatide (Byetta®, Eli Lilly and Company) 5 µg BID for the first 4 weeks and then 10 µg BID thereafter.
Mixed Protamine Zinc Recombinant Human Insulin Lispro 25RDrug
Patients in insulin group will be treated with premixed insulin analog (Humalog Mix 25, Eli Lilly and Company). The initial insulin doses are 0.4 IU/kg per day(50% before breakfast and 50% before dinner). Insulin doses are titrated following a forced schedule according to blood glucose before breakfast and dinner.
PioglitazoneDrug
Patients in thiazolidinedione group will be treated with Pioglitazone 30mg daily as single dose. The dose will be increased to 45mg daily after 4 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- the Comparison Between Treatment Groups of the Changes From Baseline in HbA1c at 48 WeeksTime frame: 48 weeks
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Beijing Hospital
Beijing, Beijing Municipality, China
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Peking University First Hospital
Beijing, Beijing Municipality, China
The Military General Hospital of Beijing PLA
Beijing, Beijing Municipality, China
The Second Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Qingyuan People's hospital
Qingyuan, Guangdong, China
The first Affiliated Hospital of Shantou University Medical College
Shantou, Guangdong, China
Shenzhen Second People's Hospital
Shenzhen, Guangdong, China
Affiliated hospital of Guangdong medical college
Zhanjiang, Guangdong, China
The first affiliated hospital of Guangxi Medical College
Nanning, Guangxi, China
The Affiliated Hospital of Guiyang Medical College
Guiyang, Guizhou, China
The 2nd Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
Second Xiangya Hospital of Central-south University
Changsha, Hunan, China
The Affiliated Hospital of Inner Mangolia Medical College
Hohhot, Inner Mongolia, China
Nanjing Drum Tower Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Zhongda Hospital of Southeast University
Nanjing, Jiangsu, China
China Medical University
Shenyang, Liaoning, China
Xijing Hospital of The Fourth Military Medical University
Xi'an, Shaanxi, China
The First Affiliated Hospital of Kunming Medical College
Kunming, Yunnan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.